Oculis: Lack Of Coverage Only Real Risk For This Solid Company
Oculis has multiple late-stage programs and catalysts. Click here to find out why I think OCS stock looks attractive.
Oculis Reports Q3 2024 Financial Results and Provides Company Updates
Significant advancement on product portfolio, including enrollment in the OCS-01 DIAMOND Phase 3 program in DME and OCS-05 Phase 2 ACUITY trial ...
Nature4y
Activating antitumor activity
The TNFRSF25 gene shares homology and chromosomal localization with genes for other costimulatory molecules, but is most closely related to TNFR1. Because TNFRSF25 appears to be divergent from ...
eLife8d
Spatial transcriptomics of meningeal inflammation reveals inflammatory gene signatures in adjacent brain parenchyma
Leptomeningeal inflammation in a mouse model of multiple sclerosis triggers deeply penetrating gene changes in underlying brain tissue, described using spatial transcriptomics.
University of Bristol7y
T cell macrophage interactions
Inflammatory processes are the body’s defence against local damage and disease. Inflammation involves the influx into organs of immune cells (white blood cells) from the blood. These cells deal with ...